Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.
Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, Galli L, Di Desidero T, Fioravanti A, Lucchesi S, Coltelli L, Ginocchi L, Allegrini G, Danesi R, Falcone A, Bocci G.
Solini A, et al. Among authors: galli l.
Oncotarget. 2015 Oct 6;6(30):28743-54. doi: 10.18632/oncotarget.4926.
Oncotarget. 2015.
PMID: 26337470
Free PMC article.